Showing results (131-140 of 194) with videos related to
Sort By:
Pageof 20
Journal of the International AIDS Society|April 1, 2017
Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohortsRimke Bijker, Awachana Jiamsakul, Cissy Kityo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project ExperienceDeborah Ford, Margaret Muzambi, Misheck J Nkhata, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 26, 2006
Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibilityDavid B Blossom, Grace Namayanja-Kaye, Joan Nankya-Mutyoba, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategiesRaph L Hamers, Kim C E Sigaloff, Annemarie M Wensing, et al.Journal of the International AIDS Society|September 28, 2017
Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failureRagna S Boerma, Torsak Bunupuradah, Dorothy Dow, et al.Journal of the International AIDS Society|December 11, 2014
Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling studyBrooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance networkRaph L Hamers, Elske Straatsma, Cissy Kityo, et al.AIDS Research and Treatment|March 9, 2012
Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method StudyT Sonia Boender, Kim C E Sigaloff, Joshua Kayiwa, et al.The Lancet. HIV|April 23, 2022
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trialNicholas I Paton, Joseph Musaazi, Cissy Kityo, et al.Antiviral Therapy|April 11, 2014
Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trialVictor Musiime, Adrian Cook, Joshua Kayiwa, et al.Pageof 20